Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with MYC and MYC/BCL2 rearrangements, especially in germinal center cell-type tumors.

Literature DB >> 33988072

Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with MYC and MYC/BCL2 rearrangements, especially in germinal center cell-type tumors.

Jennifer Chapman¹, Ramiro E Verdun², Izidore S Lossos².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 33988072 PMCID： PMC8878122 DOI： 10.1080/10428194.2021.1927020

Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022

Keyword Cloud
References

× No keyword cloud information.

12 in total

1. Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.

Authors: David K Durnick; Mark E Law; Matthew J Maurer; Yasodha Natkunam; Ronald Levy; Izidore S Lossos; Paul J Kurtin; Ellen D McPhail
Journal: Am J Clin Pathol Date: 2010-08 Impact factor: 2.493

2. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.

Authors: Luis Colomo; Ivonne Vazquez; Natalia Papaleo; Blanca Espinet; Anna Ferrer; Catalina Franco; Laura Comerma; Silvia Hernandez; Xavier Calvo; Antonio Salar; Fina Climent; José Luis Mate; Pilar Forcada; Anna Mozos; Lara Nonell; Antonio Martinez; Anna Carrio; Dolors Costa; Ivan Dlouhy; Itziar Salaverria; Jose Ignacio Martin-Subero; Armando Lopez-Guillermo; Alexandra Valera; Elias Campo
Journal: Am J Surg Pathol Date: 2017-07 Impact factor: 6.394

3. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.

Authors: Yasodha Natkunam; Shuchun Zhao; David Y Mason; Jun Chen; Behnaz Taidi; Margaret Jones; Anne S Hammer; Stephen Hamilton Dutoit; Izidore S Lossos; Ronald Levy
Journal: Blood Date: 2006-10-12 Impact factor: 22.113

4. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.

Authors: Elena Cubedo; Andrew J Gentles; Chuanxin Huang; Yasodha Natkunam; Shruti Bhatt; Xiaoqing Lu; Xiaoyu Jiang; Isabel Romero-Camarero; Aharon Freud; Shuchun Zhao; Carlos E Bacchi; Jose A Martínez-Climent; Isidro Sánchez-García; Ari Melnick; Izidore S Lossos
Journal: Blood Date: 2012-04-19 Impact factor: 22.113

5. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors: Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal: Blood Date: 2003-09-22 Impact factor: 22.113

Review 6. Double hit and double expressors in lymphoma: Definition and treatment.

Authors: Peter A Riedell; Sonali M Smith
Journal: Cancer Date: 2018-09-25 Impact factor: 6.860

Review 7. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.

Authors: Chang-Hoon Nam; Terence H Rabbitts
Journal: Mol Ther Date: 2005-11-02 Impact factor: 11.454